Paperpal Prime Logo

The Lancet Infectious Diseases : Impact Factor & More

eISSN: 1474-4457pISSN: 1473-3099

Key Metrics

CiteScore
50.3
Impact Factor
>= 25
Scite Index
0.88 5-Year SI
SNIP
10.66
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on The Lancet Infectious Diseases

The Lancet Infectious Diseases Journal Specifications

Overview
Publisher ELSEVIER SCI LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in The Lancet Infectious Diseases ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in The Lancet Infectious Diseases

Secret histories of the HIV epidemic.
  • 7 Aug 2026
  • The Lancet. Infectious diseases
Congolese hospital staff cohort admitted with infectious symptoms in the setting of the Bundibugyo virus outbreak, April and May 2026, Bunia, DR Congo.
  • 3 Aug 2026
  • The Lancet. Infectious diseases
Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16-26 years in Japan: a randomised, double-blind, placebo-controlled trial.
  • 3 Aug 2026
  • The Lancet. Infectious diseases
A defining clinical moment during the COVID-19 pandemic in Nigeria.
  • 1 Aug 2026
  • The Lancet. Infectious diseases
Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study.
  • 1 Aug 2026
  • The Lancet. Infectious diseases
Rapid recruitment for a remote long COVID clinical trial.
  • 1 Aug 2026
  • The Lancet. Infectious diseases
Secret histories of the HIV epidemic.
  • 7 Aug 2026
  • The Lancet. Infectious diseases
Congolese hospital staff cohort admitted with infectious symptoms in the setting of the Bundibugyo virus outbreak, April and May 2026, Bunia, DR Congo.
  • 3 Aug 2026
  • The Lancet. Infectious diseases
Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16-26 years in Japan: a randomised, double-blind, placebo-controlled trial.
  • 3 Aug 2026
  • The Lancet. Infectious diseases
A defining clinical moment during the COVID-19 pandemic in Nigeria.
  • 1 Aug 2026
  • The Lancet. Infectious diseases
Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study.
  • 1 Aug 2026
  • The Lancet. Infectious diseases
Rapid recruitment for a remote long COVID clinical trial.
  • 1 Aug 2026
  • The Lancet. Infectious diseases

FAQs on The Lancet Infectious Diseases